Related references
Note: Only part of the references are listed.Nanozyme-Based Enhanced Cancer Immunotherapy
Ngoc Man Phan et al.
TISSUE ENGINEERING AND REGENERATIVE MEDICINE (2022)
Immune Checkpoint Inhibitors in the Treatment of Cancer
Wissam Zam et al.
CURRENT REVIEWS IN CLINICAL AND EXPERIMENTAL PHARMACOLOGY (2022)
The mutational load and a T-cell inflamed tumour phenotype identify ovarian cancer patients rendering tumour-reactive T cells from PD-1+ tumour-infiltrating lymphocytes
Diego Salas-Benito et al.
BRITISH JOURNAL OF CANCER (2021)
The effect of PD-1 expression on tumor-associated macrophage in T cell lymphoma
J. Ruan et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2021)
SENP3 senses oxidative stress to facilitate STING-dependent dendritic cell antitumor function
Zhilin Hu et al.
MOLECULAR CELL (2021)
Mitochondrial stress induced by continuous stimulation under hypoxia rapidly drives T cell exhaustion
Nicole E. Scharping et al.
NATURE IMMUNOLOGY (2021)
Advances in the development of personalized neoantigen-based therapeutic cancer vaccines
Eryn Blass et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
Biomedical Applications of Reactive Oxygen Species Generation by Metal Nanoparticles
Roberto Canaparo et al.
MATERIALS (2021)
Therapeutic Manipulation of Tumor-associated Macrophages: Facts and Hopes from a Clinical and Translational Perspective
Paola Allavena et al.
CLINICAL CANCER RESEARCH (2021)
Dual Size/Charge-Switchable Nanocatalytic Medicine for Deep Tumor Therapy
Wencheng Wu et al.
ADVANCED SCIENCE (2021)
Immune cell-produced ROS and their impact on tumor growth and metastasis
Kilian B. Kennel et al.
REDOX BIOLOGY (2021)
PDLIM2 repression by ROS in alveolar macrophages promotes lung tumorigenesis
Liwen Li et al.
JCI INSIGHT (2021)
Venetoclax enhances T cell-mediated antileukemic activity by increasing ROS production
Jong Bok Lee et al.
BLOOD (2021)
CXCR4 promotes B cell viability by the cooperation of nuclear factor (erythroid-derived 2)-like 2 and hypoxia-inducible factor-1α under hypoxic conditions
Ju-Won Jang et al.
CELL DEATH & DISEASE (2021)
Oxidative Stress in Cancer Cell Metabolism
Saniya Arfin et al.
ANTIOXIDANTS (2021)
Oncolytic Virotherapy for Cancer: Clinical Experience
Shyambabu Chaurasiya et al.
BIOMEDICINES (2021)
Dual Inhibition of Endoplasmic Reticulum Stress and Oxidation Stress Manipulates the Polarization of Macrophages under Hypoxia to Sensitize Immunotherapy
Mengshi Jiang et al.
ACS NANO (2021)
Early phago-/endosomal escape of platinum drugs via ROS-responsive micelles for dual cancer chemo/immunotherapy
Pei-Wei Shueng et al.
BIOMATERIALS (2021)
Expansion of tumor-associated Treg cells upon disruption of a CTLA-4-dependent feedback loop
Francesco Marangoni et al.
CELL (2021)
Smart biomimetic metal organic frameworks based on ROS-ferroptosis-glycolysis regulation for enhanced tumor chemo-immunotherapy
Jie Yang et al.
JOURNAL OF CONTROLLED RELEASE (2021)
B cell heterogeneity, plasticity, and functional diversity in cancer microenvironments
Yuan Wei et al.
ONCOGENE (2021)
Photodynamic immunotherapy of cancers based on nanotechnology: recent advances and future challenges
Zhaoyuan Liu et al.
JOURNAL OF NANOBIOTECHNOLOGY (2021)
The Role of Oncogenes and Redox Signaling in the Regulation of PD-L1 in Cancer
Christophe Glorieux et al.
CANCERS (2021)
Mn3+-rich oxide/persistent luminescence nanoparticles achieve light-free generation of singlet oxygen and hydroxyl radicals for responsive imaging and tumor treatment
Dandan Ding et al.
THERANOSTICS (2021)
The double-edged roles of ROS in cancer prevention and therapy
Yawei Wang et al.
THERANOSTICS (2021)
Granulocytic myeloid-derived suppressor cells contribute to IFN-I signaling activation of B cells and disease progression through the lncRNA NEAT1-BAFF axis in systemic lupus erythematosus
Guanjun Dong et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2020)
Assessing the Magnitude of Immunogenic Cell Death Following Chemotherapy and Irradiation Reveals a New Strategy to Treat Pancreatic Cancer
Jian Ye et al.
CANCER IMMUNOLOGY RESEARCH (2020)
Scavenging reactive oxygen species selectively inhibits M2 macrophage polarization and their pro-tumorigenic function in part, via Stat3 suppression
Brandon Griess et al.
FREE RADICAL BIOLOGY AND MEDICINE (2020)
Engineering of Upconverted Metal-Organic Frameworks for Near-Infrared Light-Triggered Combinational Photodynamic/Chemo-/Immunotherapy against Hypoxic Tumors
Yulei Shao et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2020)
Immunotherapeutic Response in Tumors Is Affected by Microenvironmental ROS
Simon W. Hayward
CANCER RESEARCH (2020)
Inhibition of Vps34 reprograms cold into hot inflamed tumors and improves anti-PD-1/PD-L1 immunotherapy
Muhammad Zaeem Noman et al.
SCIENCE ADVANCES (2020)
Regulation of Selective B Cell Autophagy by the Pro-oxidant Adaptor p66SHC
Anna Onnis et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
The Superior Ability of Human BDCA3+(CD141+) Dendritic Cells (DCs) to Cross-Present Antigens Derived From Necrotic Lung Cancer Cells
Fei-fei Gu et al.
FRONTIERS IN IMMUNOLOGY (2020)
AIEgen-coupled upconversion nanoparticles eradicate solid tumors through dual-mode ROS activation
Duo Mao et al.
SCIENCE ADVANCES (2020)
Nanoscale Metal-Organic Frameworks for Cancer Immunotherapy
Kaiyuan Ni et al.
ACCOUNTS OF CHEMICAL RESEARCH (2020)
DCAF1 regulates Treg senescence via the ROS axis during immunological aging
Zengli Guo et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Catalytic nanographene oxide with hemin for enhanced photodynamic therapy
Abhishek Sahu et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Targeted scavenging of extracellular ROS relieves suppressive immunogenic cell death
Hongzhang Deng et al.
NATURE COMMUNICATIONS (2020)
GSH depletion liposome adjuvant for augmenting the photothermal immunotherapy of breast cancer
Zhanwei Zhou et al.
SCIENCE ADVANCES (2020)
Enhanced lipid biosynthesis in human tumor-induced macrophages contributes to their protumoral characteristics
Katrin Rabold et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Manipulation of Glucose Availability to Boost Cancer Immunotherapies
Federica Marchesi et al.
CANCERS (2020)
The therapeutic significance of the novel photodynamic material TPE-IQ-2O in tumors
Liyu Wang et al.
Aging-US (2020)
Fluorine assembly nanocluster breaks the shackles of immunosuppression to turn the cold tumor hot
Zhaoting Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Poor Lymphocyte Infiltration to Primary Tumors in Acral Lentiginous Melanoma and Mucosal Melanoma Compared to Cutaneous Melanoma
Yoshiyuki Nakamura et al.
FRONTIERS IN ONCOLOGY (2020)
Spatiotemporally controlled O2and singlet oxygen self-sufficient nanophotosensitizers enable thein vivohigh-yield synthesis of drugs and efficient hypoxic tumor therapy
Suisui He et al.
CHEMICAL SCIENCE (2020)
In situ fabrication of MS@MnO2 hybrid as nanozymes for enhancing ROS-mediated breast cancer therapy
Xufeng Zhu et al.
NANOSCALE (2020)
Biomimetic nanoscale metal-organic framework harnesses hypoxia for effective cancer radiotherapy and immunotherapy
Kaiyuan Ni et al.
CHEMICAL SCIENCE (2020)
Metabolism in tumor microenvironment: Implications for cancer immunotherapy
Rongchen Shi et al.
MEDCOMM (2020)
Cancer Vaccines and Oncolytic Viruses Exert Profoundly Lower Side Effects in Cancer Patients than Other Systemic Therapies: A Comparative Analysis
Volker Schirrmacher
BIOMEDICINES (2020)
Metabolic and epigenetic regulation of T-cell exhaustion
Fabien Franco et al.
NATURE METABOLISM (2020)
Essential Role of NADPH Oxidase-Dependent Production of Reactive Oxygen Species in Maintenance of Sustained B Cell Receptor Signaling and B Cell Proliferation
Yang-Yang Feng et al.
JOURNAL OF IMMUNOLOGY (2019)
Reactive oxygen species modulate macrophage immunosuppressive phenotype through the up-regulation of PD-L1
Cecilia Roux et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Oxygen in the tumor microenvironment: effects on dendritic cell function
Laurent M. Paardekooper et al.
Oncotarget (2019)
Cathepsin B: A sellsword of cancer progression
Olja Mijanovic et al.
CANCER LETTERS (2019)
Reactive Oxygen Species (ROS)-Based Nanomedicine
Bowen Yang et al.
CHEMICAL REVIEWS (2019)
Mechanism of Iron Oxide-Induced Macrophage Activation: The Impact of Composition and the Underlying Signaling Pathway
Zhengying Gu et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2019)
The mechanism(s) of action of antioxidants: From scavenging reactive oxygen/nitrogen species to redox signaling and the generation of bioactive secondary metabolites
Attila Hunyadi
MEDICINAL RESEARCH REVIEWS (2019)
How patients with an intact immune system develop head and neck cancer
Sarah Greene et al.
ORAL ONCOLOGY (2019)
Copper Chaperone for Superoxide Dismutase Promotes Breast Cancer Cell Proliferation and Migration via ROS-Mediated MAPK/ERK Signaling
Yanping Li et al.
FRONTIERS IN PHARMACOLOGY (2019)
Anti-OX40 Antibody Directly Enhances The Function of Tumor-Reactive CD8+ T Cells and Synergizes with PI3Kβ Inhibition in PTEN Loss Melanoma
Weiyi Peng et al.
CLINICAL CANCER RESEARCH (2019)
Resumption of Immune Checkpoint Inhibitor Therapy After Immune-Mediated Colitis
Hamzah Abu-Sbeih et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Target selection for CAR-T therapy
Jianshu Wei et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Crizotinib-induced immunogenic cell death in non-small cell lung cancer
Peng Liu et al.
NATURE COMMUNICATIONS (2019)
Targeting photodynamic and photothermal therapy to the endoplasmic reticulum enhances immunogenic cancer cell death
Wei Li et al.
NATURE COMMUNICATIONS (2019)
cGAS/STING axis mediates a topoisomerase II inhibitor induced tumor immunogenicity
Zining Wang et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Bile acid metabolites control TH17 and Treg cell differentiation
Saiyu Hang et al.
NATURE (2019)
Harnessing innate immunity in cancer therapy
Olivier Demaria et al.
NATURE (2019)
Delivery technologies for cancer immunotherapy
Rachel S. Riley et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Contribution of ROS and metabolic status to neonatal and adult CD8+ T cell activation
Jose Antonio Sanchez-Villanueva et al.
PLOS ONE (2019)
Macrophages as regulators of tumour immunity and immunotherapy
David G. DeNardo et al.
NATURE REVIEWS IMMUNOLOGY (2019)
Induction of tumor-specific CTL responses using the C-terminal fragment of Viral protein R as cell penetrating peptide
D. A. Gross et al.
SCIENTIFIC REPORTS (2019)
Oncolytic reovirus as a combined antiviral and anti-tumour agent for the treatment of liver cancer
Adel Samson et al.
GUT (2018)
A Pck1-directed glycogen metabolic program regulates formation and maintenance of memory CD8(+) T cells
Ruihua Ma et al.
NATURE CELL BIOLOGY (2018)
Bioinspired Hybrid Protein Oxygen Nanocarrier Amplified Photodynamic Therapy for Eliciting Anti-tumor Immunity and Abscopal Effect
Zhikuan Chen et al.
ACS NANO (2018)
Photodynamic therapy - mechanisms, photosensitizers and combinations
Stanislaw Kwiatkowski et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Immunomodulatory Function of Myeloid-Derived Suppressor Cells during B Cell-Mediated Immune Responses
Bilgenaz Ozkan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Glutathione metabolism in cancer progression and treatment resistance
Ankita Bansal et al.
JOURNAL OF CELL BIOLOGY (2018)
Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery
Li Tang et al.
NATURE BIOTECHNOLOGY (2018)
Reactive Oxygen Species: Involvement in T Cell Signaling and Metabolism
Davide G. Franchina et al.
TRENDS IN IMMUNOLOGY (2018)
Mitochondrial reactive oxygen species regulate the induction of CD8(+) T cells by plasmacytoid dendritic cells
Marine Oberkampf et al.
NATURE COMMUNICATIONS (2018)
The Role of Reactive Oxygen Species in Regulating T Cell-mediated Immunity and Disease
Emily L. Yarosz et al.
IMMUNE NETWORK (2018)
The pro-oxidant adaptor p66SHC promotes B cell mitophagy by disrupting mitochondrial integrity and recruiting LC3-II
Anna Onnis et al.
AUTOPHAGY (2018)
SENP3 maintains the stability and function of regulatory T cells via BACH2 deSUMOylation
Xiaoyan Yu et al.
NATURE COMMUNICATIONS (2018)
Interleukin-10 produced by myeloid-derived suppressor cells is critical for the induction of Tregs and attenuation of rheumatoid inflammation in mice
Min-Jung Park et al.
SCIENTIFIC REPORTS (2018)
Cancer Treatment through Nanoparticle-Facilitated Fenton Reaction
Hadi Ranji-Burachaloo et al.
ACS NANO (2018)
Reactive Oxygen Species and Their Implications on CD4+ T Cells in Type 1 Diabetes
Dana M. Previte et al.
ANTIOXIDANTS & REDOX SIGNALING (2018)
Reactive Oxygen Species as Regulators of MDSC-Mediated Immune Suppression
Kim Ohl et al.
FRONTIERS IN IMMUNOLOGY (2018)
CD4+ T cell help in cancer immunology and immunotherapy
Jannie Borst et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Reactive Oxygen Species: A Key Constituent in Cancer Survival
Seema Kumari et al.
BIOMARKER INSIGHTS (2018)
The concept of immune surveillance against tumors. The first theories
Domenico Ribatti
ONCOTARGET (2017)
The Promise and Challenges of CAR-T Gene Therapy
Bridget M. Kuehn
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
New development in CAR-T cell therapy
Zhenguang Wang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Allergy-Inducing Chromium Compounds Trigger Potent Innate Immune Stimulation Via ROS-Dependent Inflammasome Activation
Christian Adam et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2017)
CAR T-cell therapy effective in B acute lymphoblastic leukaemia
Mai Wang
LANCET ONCOLOGY (2017)
Transient Opening of the Mitochondrial Permeability Transition Pore Induces Microdomain Calcium Transients in Astrocyte Processes
Amit Agarwal et al.
NEURON (2017)
Mitochondrial activation chemicals synergize with surface receptor PD-1 blockade for T cell-dependent antitumor activity
Kenji Chamoto et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
ROS in Cancer: The Burning Question
Iok In Christine Chio et al.
TRENDS IN MOLECULAR MEDICINE (2017)
Reduction-oxidation pathways involved in cancer development: a systematic review of literature reviews
Xin Gao et al.
ONCOTARGET (2017)
PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome
Hashem O. Alsaab et al.
FRONTIERS IN PHARMACOLOGY (2017)
Type I Interferons and Natural Killer Cell Regulation in Cancer
Lena Mueller et al.
FRONTIERS IN IMMUNOLOGY (2017)
Cancer immunotherapy: Historical Perspective of a Clinical Revolution and emerging Preclinical Animal Models
William K. Decker et al.
FRONTIERS IN IMMUNOLOGY (2017)
Reolysin and Histone Deacetylase Inhibition in the Treatment of Head and Neck Squamous Cell Carcinoma
Alena C. Jaime-Ramirez et al.
MOLECULAR THERAPY-ONCOLYTICS (2017)
Attenuation of CD4+ CD25+ Regulatory T Cells in the Tumor Microenvironment by Metformin, a Type 2 Diabetes Drug
Yuki Kunisada et al.
EBIOMEDICINE (2017)
Reactive oxygen species are required for driving efficient and sustained aerobic glycolysis during CD4+ T cell activation
Dana M. Previte et al.
PLOS ONE (2017)
Catalase, a remarkable enzyme: targeting the oldest antioxidant enzyme to find a new cancer treatment approach
Christophe Glorieux et al.
BIOLOGICAL CHEMISTRY (2017)
Metabolic Regulation of T Cell Longevity and Function in Tumor Immunotherapy
Rigel J. Kishton et al.
CELL METABOLISM (2017)
Monocytic myeloid-derived suppressor cells regulate T-cell responses against vaccinia virus
Carl Fortin et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2017)
Oncolytic virus therapy: A new era of cancer treatment at dawn
Hiroshi Fukuhara et al.
CANCER SCIENCE (2016)
The Emerging Hallmarks of Cancer Metabolism
Natalya N. Pavlova et al.
CELL METABOLISM (2016)
Oxidative stress modulates the cytokine response of differentiated Th17 and Th1 cells
Thiruvaimozhi Abimannan et al.
FREE RADICAL BIOLOGY AND MEDICINE (2016)
Development of immuno-oncology drugs - from CTLA4 to PD1 to the next generations
Axel Hoos
NATURE REVIEWS DRUG DISCOVERY (2016)
Core-shell nanoscale coordination polymers combine chemotherapy and photodynamic therapy to potentiate checkpoint blockade cancer immunotherapy
Chunbai He et al.
NATURE COMMUNICATIONS (2016)
Classifying Cancers Based on T-cell Infiltration and PD-L1
Michele W. L. Teng et al.
CANCER RESEARCH (2015)
The role of antioxidants in the chemistry of oxidative stress: A review
Aurelia Magdalena Pisoschi et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Overall Survival and Long-Term Safety of Nivolumab (Anti-Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer
Scott N. Gettinger et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
High-Dose Nicotinamide Suppresses ROS Generation and Augments Population Expansion during CD8+ T Cell Activation
Ho Jin Choi et al.
MOLECULES AND CELLS (2015)
Combination cancer immunotherapy and new immunomodulatory targets
Kathleen M. Mahoney et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
The Evolving Role of Immune Checkpoint Inhibitors in Cancer Treatment
Gregory K. Pennock et al.
ONCOLOGIST (2015)
Mitochondrial function provides instructive signals for activation-induced B-cell fates
Kyoung-Jin Jang et al.
NATURE COMMUNICATIONS (2015)
Glucose metabolism regulatesT cell activation, differentiation, and functions
Clovis S. Palmer et al.
FRONTIERS IN IMMUNOLOGY (2015)
Anti-oxidant capacity and anti-tumor T cell function: A direct correlation
Pravin Kesarwani et al.
ONCOIMMUNOLOGY (2015)
Survival follow-up and ipilimumab retreatment of patients with advanced melanoma who received ipilimumab in prior phase II studies
C. Lebbe et al.
ANNALS OF ONCOLOGY (2014)
Nox Enzymes and New Thinking on Reactive Oxygen: A Double-Edged Sword Revisited
J. David Lambeth et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 9 (2014)
Immune-based mechanisms of cytotoxic chemotherapy: implications for the design of novel and rationale-based combined treatments against cancer
L. Bracci et al.
CELL DEATH AND DIFFERENTIATION (2014)
Tumor-Associated Macrophages: From Mechanisms to Therapy
Roy Noy et al.
IMMUNITY (2014)
Cell Death-Associated Molecular-Pattern Molecules: Inflammatory Signaling and Control
Beatriz Sangiuliano et al.
MEDIATORS OF INFLAMMATION (2014)
Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel?
Simran S. Sabharwal et al.
NATURE REVIEWS CANCER (2014)
Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma
Jedd D. Wolchok et al.
PHARMACEUTICAL SCIENCE TO IMPROVE THE HUMAN CONDITION: PRIX GALIEN USA 2012 (2013)
Immunogenic Cell Death in Cancer Therapy
Guido Kroemer et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
Oxidative Stress in Malignant Melanoma Enhances Tumor Necrosis Factor-α Secretion of Tumor-Associated Macrophages That Promote Cancer Cell Invasion
Xuzhu Lin et al.
ANTIOXIDANTS & REDOX SIGNALING (2013)
Cathepsin B as a cancer target
Christopher S. Gondi et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2013)
Mitochondria Are Required for Antigen-Specific T Cell Activation through Reactive Oxygen Species Signaling
Laura A. Sena et al.
IMMUNITY (2013)
Mitochondrial ROS Fire Up T Cell Activation
Michael P. Murphy et al.
IMMUNITY (2013)
Clinical trials of human papillomavirus vaccines and beyond
Matti Lehtinen et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2013)
The Warburg effect: Insights from the past decade
Mohita Upadhyay et al.
PHARMACOLOGY & THERAPEUTICS (2013)
Concepts of oxidative stress and antioxidant defense in Crohn's disease
Mohammed A. Alzoghaibi
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
History of myeloid-derived suppressor cells
James E. Talmadge et al.
NATURE REVIEWS CANCER (2013)
Glutathione levels in human tumors
Michael P. Gamcsik et al.
BIOMARKERS (2012)
Elevated serum soluble CD40 ligand in cancer patients may play an immunosuppressive role
Jianping Huang et al.
BLOOD (2012)
Immunogenic cell death and DAMPs in cancer therapy
Dmitri V. Krysko et al.
NATURE REVIEWS CANCER (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
Development of human CD4+FoxP3+ regulatory T cells in human stem cell factor-, granulocyte-macrophage colony-stimulating factor-, and interleukin-3-expressing NOD-SCID IL2Rγnull humanized mice
Eva Billerbeck et al.
BLOOD (2011)
PROVENGE (Sipuleucel-T) in Prostate Cancer: The First FDA-Approved Therapeutic Cancer Vaccine
Martin A. Cheever et al.
CLINICAL CANCER RESEARCH (2011)
Cancer Immunotherapy Comes of Age
Suzanne L. Topalian et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Ncf1 (p47phox) Is Essential for Direct Regulatory T Cell Mediated Suppression of CD4+Effector T Cells
Olga Efimova et al.
PLOS ONE (2011)
Treating cancer with genetically engineered T cells
Tristen S. Park et al.
TRENDS IN BIOTECHNOLOGY (2011)
Cytokines and the inception of CD8 T cell responses
Maureen A. Cox et al.
TRENDS IN IMMUNOLOGY (2011)
Functional Anatomy of T Cell Activation and Synapse Formation
David R. Fooksman et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)
Immunogenic Tumor Cell Death for Optimal Anticancer Therapy: The Calreticulin Exposure Pathway
Laurence Zitvogel et al.
CLINICAL CANCER RESEARCH (2010)
Reactive Oxygen Species Level Defines Two Functionally Distinctive Stages of Inflammatory Dendritic Cell Development from Mouse Bone Marrow
Kuo-Ching Sheng et al.
JOURNAL OF IMMUNOLOGY (2010)
How mitochondria produce reactive oxygen species
Michael P. Murphy
BIOCHEMICAL JOURNAL (2009)
Naturally occurring regulatory T cells show reduced sensitivity toward oxidative stress-induced cell death
Dimitrios Mougiakakos et al.
BLOOD (2009)
Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death
Theocharis Panaretakis et al.
EMBO JOURNAL (2009)
IL-1 acts directly on CD4 T cells to enhance their antigen-driven expansion and differentiation
Shlomo Z. Ben-Sasson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Oxidative microenvironment exerts an opposite regulatory effect on cytokine production by Th1 and Th2 cells
Barbara Frossi et al.
MOLECULAR IMMUNOLOGY (2008)
Molecular characteristics of immunogenic cancer cell death
A. Tesniere et al.
CELL DEATH AND DIFFERENTIATION (2008)
Signalling to transcription:: Store-operated Ca2+ entry and NFAT activation in lymphocytes
Yousang Gwack et al.
CELL CALCIUM (2007)
Mitochondrial oxidative stress: Implications for cell death
Sten Orrenius et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2007)
The role of oxidative stress in adult critical care
E Crimi et al.
FREE RADICAL BIOLOGY AND MEDICINE (2006)
ROS as signalling molecules in T cells - evidence for abnormal redox signalling in the autoimmune disease, rheumatoid arthritis
HR Griffiths
REDOX REPORT (2005)
Cancer immunotherapy: moving beyond current vaccines
SA Rosenberg et al.
NATURE MEDICINE (2004)
Metal-induced oxidative stress and signal transduction
SS Leonard et al.
FREE RADICAL BIOLOGY AND MEDICINE (2004)
The three Es of cancer immunoediting
GP Dunn et al.
ANNUAL REVIEW OF IMMUNOLOGY (2004)
Generation and function of reactive oxygen species in dendritic cells during antigen presentation
H Matsue et al.
JOURNAL OF IMMUNOLOGY (2003)
Inhibition of myeloid cell differentiation in cancer: the role of reactive oxygen species
S Kusmartsev et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2003)
Activation-induced cell death in T cells
DR Green et al.
IMMUNOLOGICAL REVIEWS (2003)
Human papillomavirus and cervical cancer
EM Burd
CLINICAL MICROBIOLOGY REVIEWS (2003)
Armed therapeutic viruses: Strategies and challenges to arming oncolytic viruses with therapeutic genes
TW Hermiston et al.
CANCER GENE THERAPY (2002)
Cancer immunoediting: from immunosurveillance to tumor escape
GP Dunn et al.
NATURE IMMUNOLOGY (2002)
T-cell regulation by CD28 and CTLA-4
ML Alegre et al.
NATURE REVIEWS IMMUNOLOGY (2001)
Structural basis for co-stimulation by the human CTLA-4/B7-2 complex
JCD Schwartz et al.
NATURE (2001)
Share Paper
